Plod

Judy Lewent

Judy Lewent is responsible for the worldwide financial, corporate development, and corporate licensing matters, as well as for Merck's current joint venture relationships with Johnson & Johnson and Aventis CropScience (and for Merck's former joint venture relationships with Astra, Chughai, and DuPont). Judy is Chairman as well as Board member of Merck Capital Ventures and serves on the Board of the Merck/Schering-Plough Partnerships. She is a member of Merck's Management Committee, a senior management group which makes strategic decisions for the Company.

Judy joined Merck in 1980 as Director of Acquisitions and Capital Analysis. She was promoted to Assistant Controller of the Merck Research Laboratories in 1983 and to Executive Director of Financial Evaluation and Analysis in 1985. Judy was elected Vice President and Treasurer in October 1987, to Vice President for Finance and Chief Financial Officer in March 1990, to Senior Vice President and Chief Financial Officer in December 1992, and to Executive Vice President and Chief Financial Officer in February 2001.

Judy Lewent is a member of the Board of Directors of Dell Computer, Motorola, Quaker Oats, and the National Bureau of Economic Research; a trustee of the Rockefeller Family Trust; a life member of the MIT Corporation; a member of the University of Pennsylvania Health System Trustee Board Executive Committee; and a member of the RAND Health Board of Advisors.

Judy earned a B.S. in Economics from Goucher College in 1970 and an M.S. in Management from MIT's Sloan School of Management in 1972. In 1998, an Honorary Doctorate of Humane Letters was bestowed upon Judy Lewent by Goucher College; and in May 2000, she received an Honorary Doctorate of Engineering from Stevens Institute of Technology.